- Home
- OLMA vs COO Comparison
OLMA vs COO Comparison
Compare OLMA & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- COO
- Stock Information
- Founded
- OLMA 2006
- COO 1980
- Country
- OLMA United States
- COO United States
- Employees
- OLMA N/A
- COO N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- COO Ophthalmic Goods
- Sector
- OLMA Health Care
- COO Health Care
- Exchange
- OLMA Nasdaq
- COO Nasdaq
- Market Cap
- OLMA 465.4M
- COO N/A
- IPO Year
- OLMA 2020
- COO N/A
- Fundamental
- Price
- OLMA $6.10
- COO $93.44
- Analyst Decision
- OLMA Strong Buy
- COO Buy
- Analyst Count
- OLMA 5
- COO 12
- Target Price
- OLMA $26.25
- COO $117.00
- AVG Volume (30 Days)
- OLMA 1.2M
- COO 1.8M
- Earning Date
- OLMA 11-12-2024
- COO 12-05-2024
- Dividend Yield
- OLMA N/A
- COO N/A
- EPS Growth
- OLMA N/A
- COO 32.43
- EPS
- OLMA N/A
- COO 1.96
- Revenue
- OLMA N/A
- COO $3,895,400,000.00
- Revenue This Year
- OLMA N/A
- COO $8.92
- Revenue Next Year
- OLMA N/A
- COO $6.74
- P/E Ratio
- OLMA N/A
- COO $47.67
- Revenue Growth
- OLMA N/A
- COO 8.41
- 52 Week Low
- OLMA $5.56
- COO $84.76
- 52 Week High
- OLMA $16.78
- COO $112.38
- Technical
- Relative Strength Index (RSI)
- OLMA 27.05
- COO 32.35
- Support Level
- OLMA $5.56
- COO $91.22
- Resistance Level
- OLMA $6.87
- COO $100.47
- Average True Range (ATR)
- OLMA 0.81
- COO 2.45
- MACD
- OLMA -0.28
- COO -0.71
- Stochastic Oscillator
- OLMA 10.12
- COO 14.41
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.